These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
742 related items for PubMed ID: 27261587
1. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model. El-Mahdy NA, El-Sayad ME, El-Kadem AH. Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587 [Abstract] [Full Text] [Related]
2. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. Sharma AK, Kanawat DS, Mishra A, Dhakad PK, Sharma P, Srivastava V, Joshi S, Joshi M, Raikwar SK, Kurmi MK, Srinivasan BP. J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552 [Abstract] [Full Text] [Related]
3. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat. Bishnoi HK, Mahadevan N, Balakumar P. Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657 [Abstract] [Full Text] [Related]
4. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy. Mulay SR, Gaikwad AB, Tikoo K. Chem Biol Interact; 2010 Apr 29; 185(2):137-42. PubMed ID: 20223228 [Abstract] [Full Text] [Related]
5. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ. J Ethnopharmacol; 2011 Dec 08; 138(3):731-6. PubMed ID: 22027446 [Abstract] [Full Text] [Related]
6. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. Rao RP, Jain A, Srinivasan B. J Renin Angiotensin Aldosterone Syst; 2011 Sep 08; 12(3):169-75. PubMed ID: 21421651 [Abstract] [Full Text] [Related]
7. The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model. Elmas O, Erbas O, Yigitturk G. Biomed Pharmacother; 2016 Oct 08; 83():392-396. PubMed ID: 27424320 [Abstract] [Full Text] [Related]
8. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats. Huang H, Jiang Y, Mao G, Yuan F, Zheng H, Ruan Y, Wu T. J Sci Food Agric; 2017 Mar 08; 97(4):1359-1366. PubMed ID: 27363537 [Abstract] [Full Text] [Related]
9. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Kuo CW, Shen CJ, Tung YT, Chen HL, Chen YH, Chang WH, Cheng KC, Yang SH, Chen CM. Life Sci; 2015 Aug 15; 135():77-86. PubMed ID: 26006040 [Abstract] [Full Text] [Related]
10. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats. Hofni A, El-Moselhy MA, Taye A, Khalifa MM. Eur J Pharmacol; 2014 Dec 05; 744():173-82. PubMed ID: 25446917 [Abstract] [Full Text] [Related]
13. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Maheshwari RA, Balaraman R, Sen AK, Seth AK. Indian J Pharmacol; 2014 Dec 05; 46(6):627-32. PubMed ID: 25538335 [Abstract] [Full Text] [Related]